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ABSTRACT
Plants provide excellent sources of medicinal compounds. Over 5000 flavonoids have 
been isolated and identified from plant sources. Flavonoids are polyphenolic compounds 
mainly recognized as pigments which produce the colors found in flowers, fruit and leaves. 
Dietary polyphenols are commonly found in plants and are abundant in fruit, vegetables, 
chocolate, and nuts. These polyphenols also found in beverages including tea, coffee, 
wine, and soy milk. Flavonoids are known to lower glucose levels, decrease cholesterol 
and triglycerides, and increase liver enzyme levels most likely by stimulating pancreatic 
insulin release. By activating cell-signaling pathways involved in controlling blood glucose 
levels, flavonoids aid in carbohydrate digestion, and adipose deposition. Flavonoids 
containing isoflavones, flavanols, flavanones, flavonols, flavones, and anthocyanins 
have been studied from clinic study until pre clinic study. However, not all of the studies 
conducted had adequate results. Isoflavone is one of the potential flavonoids that still can 
be explored for future research. Research on isoflavone supplementation in animals and 
humans in reducing blood glucose levels is still limited. Short-term supplementation did 
not improve blood glucose levels in postmenopausal women, while other studies suggest 
that the long-term isoflavone supplementation can reduce postmenopausal blood glucose 
levels. These findings found that isoflavone is a component of flavonoids that have potency 
in reducing blood glucose levels. 
ABSTRAK
Tanaman merupakan sumber senyawa obat yang bagus. Lebih dari 5000 flavonoid telah di 
isolasi dan di identifikasi dari tumbuhan. Flavonoid merupakan senyawa polifenol terutama 
dikenal sebagai pigmen yang bertanggung jawab terhadap beberapa warna bunga, buah 
dan daun. Polifenol diet merupakan senyawa kimia yang berasal dari tumbuhan yang 
banyak terdapat dalam buah, sayuran, coklat, dan  kacang, juga terdapat pada minuman 
seperti teh, kopi, anggur dan susu kedelai. Flavonoid dapat menurunkan kadar glukosa 
darah, kolesterol dan trigliserida plasma secara bermakna dan meningkatkan aktivitas 
glukokinase hepar dengan meningkatkan pelepasan insulin dari sel beta pankreas. 
Flavonoid mengatur pencernaan karbohidrat, deposisi jaringan adiposa, pelepasan insulin, 
dan ambilan glukosa dalam jaringan yang merespon terhadap insulin melalui beberapa 
jalur signaling sel. Flavonoid terdiri dari isoflavon, flavanol, flavanon, flavonol, flavon, dan 
antosiani telah dikaji mulai dari uji pre klinik sampai klinik. Namun, tidak semua penelitian 
yang dilakukan menunjukkan hasil yang sesuai. Salah satu flavonoid yang mungkin 
memberi harapan untuk penelitian masa depan adalah isoflavon. Penelitian tentang 
suplementasi isoflavon pada hewan dan manusia dalam menurunkan kadar glukosa 
darah masih terbatas. Suplementasi isoflavon jangka pendek tidak memperbaiki kadar 
glukosa darah pada wanita postmenopausal, sedangkan penelitian lain menunjukkan 
bahwa suplementasi isoflavon jangka panjang dapat menurunkan kadar glukosa darah 
wanita postmenopausal. Oleh karena itu isoflavon sebagai komponen flavonoid telah 
terbukti dapat menurunkan kadar glukosa darah.
Keywords: flavonoid – isoflavone - blood glucose level - G-6-Pase enzyme - PEPCK 
enzyme
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INTRODUCTION
Plants are excellent sources of medicinal 
compounds. Over 5000 flavonoids have 
been isolated and identified from plant 
sources. Flavonoids are polyphenolic 
compounds mainly recognized as pigments 
which produce the colors found in flowers, 
fruit and leaves. Beginning more than 20 
years ago many studies have focused on 
polyphenol compounds derived from plants 
because they are beneficial for human 
health.1 The World Health Organization 
(WHO) recommends evaluating traditional 
medicinal plants because they are effective, 
non-toxic, and have few or no side effects 
so that they are excellent candidates for oral 
treatment.
Recently, the flavonoid rich fraction 
of pomegranate (PGFF) was shown to 
decrease fasting blood glucose significantly 
in streptozotocin (STZ) induced diabetic 
rats.2 Treatment with O-prenilated flavonoid 
constituents in Melicope lunu-ankenda at 
dose 10mg/kg BW given to diabetic rats 
significantly reduced blood glucose levels 
after 2 weeks returning it very close to 
normal values.3 Jiang et al.4 treated diabetic 
rats with fenugreek flavonoids at dose 0.5 g 
in 10 mL water intragastrically for 28 days 
and found significantly decreased levels of 
fasting blood glucose (FBG).
Another study in humans showed extract 
of cocoa (EC) and cocoa polyphenolic 
extract (CPE) can improve insulin sensitivity 
of HepG2 cells induced with high glucose 
levels. Beneficial effects were demonstrated 
for liver function and involved mitigating 
the signaling pathways for insulin while 
modulating production and uptake of 
glucose. 5 Similarly, research by Ferguson et 
al.6 showed soy products rich in isoflavones 
could lower fasting insulin in European soy 
consumers and lower glucose levels post-
OGTT significantly compared to non-soy 
consumers.
Research by Yun et al.7 indicated that 
soy isoflavones reduced body weight and 
improved glucose metabolism significantly 
in non-Asian postmenopausal women. 
Furthermore, the longer the treatment with 
soy isoflavones, the greater the decrease in 
blood glucose levels.   This review article 
comprehensively describes the main 
categories of the bioflavonoid family, with 
particular emphasis on the efficacy of 
polyphenols such as isoflavones which can 
be used in oral supplementation for control 
treatment to decrease blood glucose levels.
DISCUSSION
Flavonoids 
Flavonoids are polyphenolic compounds 
mainly recognized as pigments which 
produce the colors found in flowers, fruit 
and leaves and contain many health benefits. 
Their salutogenetic effects range from 
treatments for arteriosclerosis and heart 
disease to hepatic dysfunction and insulin 
insensitivity. As chemical compounds, 
most polyphenols are poorly soluble in 
water containing a 15-carbon (C6–C3–C6) 
skeleton. They consist of two benzene rings 
joined together by a short chain of three 
carbon atoms. Dietary polyphenols are 
commonly found in plants and are abundant 
in fruit, vegetables, chocolate, and nuts. 
These polyphenols also occur in beverages 
including tea, coffee, wine, and soy milk.8,9 
Flavonoids are known to lower blood glucose 
levels, decrease cholesterol and triglycerides, 
and increase liver enzyme levels most likely 
by stimulating pancreatic insulin release. 
By activating cell-signaling pathways 
involved in controlling blood glucose levels, 
flavonoids aid in carbohydrate digestion, and 
adipose deposition. Under oxidative stress 
conditions, research showed the negative 
effects of the accumulation of free radicals 
such as reactive oxygen species (ROS) and 
reactive nitrogen species (RNS). ROS and 
RNS are cellular by-products of human 
metabolism and contribute to a variety of 
life-threatening diseases such as coronary 
heart diseases, Type 2 diabetes mellitus 
(T2DM), obesity and cancers.10 Our previous 
study demonstrated that the flavonoids from 
Swietenia macrophyla King seeds can lower 
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blood glucose levels by down regulating 
the hepatic enzyme, phosphoenolpyruvate 
carboxykinase (PEPCK).11
Flavonoids are absorbed by active 
transport. There are two compartments 
involved in the metabolism of flavonoids. 
The first compartment includes the small 
intestine, liver, and kidneys. The second 
compartment is the colon. Before absorption 
flavonoids are held in hydrolysis by 
lactase phlorizin hydrolase (LPH) that 
catalyzes some glycosides and cytosolic 
β-glucosidase (CBG) that are involved 
intracellularly with broad specificity.12,13 
After absorption, flavonoids undergo three 
main processes: methylation, sulfation and 
glucuronidation.8,14,15 In the small intestine, 
some flavonoids are not absorbed while 
most absorbed are then secreted with bile 
in the large intestine. This process of biliary 
secretion is not well-understood in humans, 
while nearly 40% of absorbed (þ)-catechin 
was secreted with bile back into the rat small 
intestine.16 
Classification of flavonoid
Flavanols
Rich in flavanols (FIGURE 1), 
green tea extract taken orally has been 
found to have many health benefits and 
to be a significant source of monomeric 
flavan-3-ols. These beneficial flavanols 
include epicatechingallate (ECG) and 
epigallocatechin gallate (EGCG), which 
can prevent glucose absorption from 
intestinal lumen. The beneficial effects of 
(−)-catechin enhanced insulin-dependent 
glucose uptake in differentiated adipocytes 
in T2DM cases.17 Epigallocatechin 3-gallate 
acts like insulin, and as a supplement, 
the drug candidate enhances tyrosine 
phosphorylation of the insulin receptor 
and insulin receptor substrate-1 (IRS-1), 
as well as PI3K activity, while reducing 
phosphoenolpyruvate carboxykinase 
gene expression mediated by PI3K.18 The 
(−)-epicatechin gallate, myricetin, quercetin, 
apigenin, (−)-epigallocatechin gallate, and 
(−)-epigallocatechin are known to reduce 
glucose absorption by competitive inhibition 
of sodium dependent glucose transporter-1 
(GLUT-1).19
FIGURE 1. Chemical structure of flavanols20
Flavanones 
The two major flavanones (FIGURE 2) 
are naringenin and hesperidin, which are rich 
in citrus fruits such as grapes, tomatoes, and 
oranges.21 In vivo studies of Cochlospermum 
vitifolium (Willd.) Spreng containing narin-
genin was found to decrease blood glucose 
levels in healthy male Wistar rats.22 Previous 
studies  showed naringenin supports mus-
cle glucose uptake depending on the dose 
but independent of insulin.23,24 One study 
found treatment of naringenin at a dose of 
25 mg/kg BW for 45 days in a diabetic rat 
model significantly lowered hyperglycemia 
and hyperinsulinemia, after restoring lip-
id profiles, decreasing lipid peroxidation, 
through enhanced antioxidant activities and 
improved liver function markers.25,26 Hes-
peridin in doses of 10 g/kg in the diet was 
found to lower blood glucose level through 
changes in glucose regulating enzymes.27 In 
a hyperglycemic mice model, hesperidin had 
beneficial effects on glycolytic and glucone-
ogenesis enzymes involved in hepatic glu-
cose metabolism.28,29
FIGURE 2. Chemical structure of flavanones20
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Flavonols 
The major flavonols (FIGURE 3) 
are quercetin, kaempferol, and myricetin. 
Quercetin and its derivatives in berries 
considered the primary bioactive components 
with many health benefits were found to 
activate AMPK and increase glucose levels 
in muscle cell uptake. Treatment of quercetin 
reduced hyperglycemia-stimulating GLUT-
4 and hepatic glucokinase (GK). Health 
benefits included increased liver glucose 
uptake, and lower hepatic glycogenolysis and 
gluconeogenesis.30-32 Oral supplementation of 
0.5% quercetin for 2 weeks improved serum 
insulin level and lowered blood glucose. In 
the same STZ-induced diabetic mice model, 
intraperitoneal (IP) injection of quercetin 
caused lowered levels of hyperglycemia and 
improved glucose tolerance. Health benefits 
also included higher liver glucokinase 
activity and reductions in plasma cholesterol 
and triglycerides.33 In an obese diabetic 
mice model, dietary supplementation of 
0.04% quercetin lowered blood glucose 
and increased insulin resistance.34 One 
study in 6-week-old male Wistar rats on a 
high-fat high-sucrose diet found quercetin 
supplementation at 30 mg/kg BW per day 
for six weeks helped to lower basal levels 
of glucose and insulin.35 Quercetin has been 
proven to be effective against obesity and 
diabetes by blocking digestion of intestinal 
starch and liver glucose production. 
Quercetin also increases skeletal muscle 
glucose uptake, and protects pancreatic 
islets from damage. Kaempferol extracted 
from the leaves of the Brazilian orchid 
tree (Bauhinia forficata) has been found to 
reduce hyperglycemia and increased glucose 
uptake similar to the action of insulin.36 
Kaempferol caused the increase of glucose 
uptake in the rat soleus muscle through PI3K 
and protein kinase C (PKC) pathways and by 
synthesizing new glucose transporters37. As 
a potent antioxidant kaempferol increased 
TNF-α and IL-1β expression as well as 
lipid peroxidation. The resulting benefits 
improved antioxidant defense.38,39 
FIGURE 3. Chemical structure of flavonol20
Flavones
The major dietary flavones (FIGURE 4) 
are apigenin and luteolin.40,41 Intraperitoneal 
administration of apigenin significantly 
acts as an insulin regulating agent with 
anti-hyperglycemic effects.22 According to 
Ding et al.42 luteolin was reported to have 
insulin potentiate action and increased 
expression and transcriptional activation 
of the PPAR gamma target gene. Luteolin 
positively influenced metabolic pathways 
in insulin resistance and pathophysiology 
of diabetes mellitus by inhibiting MCP-1 
circulating levels and resistin, among other 
inflammatory molecules.
 
FIGURE 4. Chemical structure of flavones20
Anthocyanins 
Bilberries are an abundant source of 
anthocyanins (FIGURE 5) and bilberry 
extract (BBE) has been shown to improve 
hyperglycemia and insulin sensitivity by 
influencing AMP-activated protein kinase 
(AMPK), GLUT-4, and metabolic enzymes.42 
Cyanidin also protects hepatocytes from 
damage triggered by high levels of glucose 
by reducing the mitochondiia-mediated 
apoptotic pathways and improving 
antioxidant status by triggering AKT and 
inactivating JNK.43,44, 
O
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FIGURE 5. Chemical structure of anthocyanins45
Isoflavones 
Isoflavones are a type of flavonoids 
found in legumes, including soybean and 
soy products. Soy food products contain 
two main isoflavones: daidzein and 
genistein.40 Research has shown isoflavone 
administration can lower blood glucose 
levels.46 Supplementation with isoflavones 
is known to suppress the activities of 
gluconeogenic enzymes such as PEPCK 
and G6Pase. Soy isoflavones were also 
found to decrease β-oxidation of fatty acids 
and lipid accumulation while soy dietary 
supplementation could increase beneficial 
lipogenesis in the liver.47
One study recently found that a soy-
supplemented diet could provide a number 
of overall health benefits. Mice fed 198 
ppm daidzein and 286 ppm genistein 
for their entire life demonstrated better 
lipid profile and glucose metabolism.48 
Supplementation with soy isoflavones also 
increased phosphorylation of AMPK. These 
health benefits included positive metabolic 
changes, such as improved mitochondrial 
biogenesis and glucose uptake in the 
skeletal muscle.48 There were also a number 
of reports documenting decreased blood 
glucose, TGFβ 1, and HbA1C levels.49,50
Other research found genistein was 
beneficial in the treatment of diabetes and 
could improve plasma lipids51, and was 
shown to increase insulin sensitivity.52 
Genistein could also reduce fasting glucose 
levels in non-genetic diabetes mice.52 
Supporting these findings, genistein 
supplementation was beneficial to improve 
glucose tolerance and hyperglycemia. 
It was also found to increase islet β-cell 
expression and prolong the life of mice in a 
diabetic model induced by STZ.53  In dietary 
supplementation, isoflavones, soy protein, 
or genistein in combination, can have many 
health benefits, especially for balancing the 
body’s metabolism. In non-obese diabetic 
mice models, daidzein or genistein can 
prevent diabetes and improve glucose 
homeostasis through balancing pancreatic 
β-cell function.47
Daily doses of isoflavones in the form of 
100 mg of aglycones for a year were found 
to improve insulin sensitivity and blood 
lipid levels of post-menopausal women 
with T2DM.54 Oppositely, daily isoflavone 
doses of 132 mg for 3 months showed no 
improvement in plasma A1C, blood glucose, 
nor insulin levels in postmenopausal women 
with T2DM.18 While these contradictory 
results may possibly be due to treatment 
dosage and duration differences, a number 
of studies, both in vitro and in vivo 
demonstrated health benefits of isoflavone 
supplementation finding many anti-obesity 
and anti-diabetic results. Genistein was 
seen at dose 0.02% to suppress the onset 
of DM and increased glucose homeostasis 
through the function of pancreatic beta cell 
stabilization in non-obese diabetic mice.47
FIGURE 6. Chemical structure of isoflavones20
Role of isoflavone in reducing the blood 
glucose
All members of the bioflavonoid family 
are important for health due to the ability 
to control blood glucose levels. Recent 
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fatty acids and lipogenesis in liver. PEPCK 
is an essential enzyme for gluconeogenesis 
so that the enzyme suppression results in 
the formation of glucose from sources other 
than dietary carbohydrates and as a result it 
can reduce blood glucose levels in rat liver.47 
G6Pase is an enzyme that converts G6P to 
glucose so that suppression of G6Pase also 
results in a decrease in blood glucose levels. 
Meta-analysis by Zhan et al.7 reported that soy 
isoflavone supplementation significantly 
reduced body weight and improved glucose 
metabolism compared in non-Asian 
postmenopausal women.7 Isoflavones at 
dose 100 mg for one year in postmenopausal 
women can improve insulin sensitivity and 
blood lipid parameter, but low doses for 
only 3 months cannot improve plasma A1C, 
blood glucose and insulin levels.20,54 Soy 
supplements have been shown to improve 
lipid profile, metabolism of glucose, 
increase AMPK phosphorylation and cause 
favorable metabolic changes and skeletal 
muscle glucose uptake, while decreasing 
KGD, TGFβ1 and HbA1C in mice.48-50 
Genistein reduces the expression of PPARs 
and C/EBP, modulates glucose metabolism 
and insulin levels, improves lipids so insulin 
sensitivity increases, and improves glucose 
tolerance and hyperglycemia.52,53,55,56 It 
also increases beta cell proliferation by 
modulating signaling pathways (activation 
calmodulin kinase II and Ca 2+ signaling),57 
and suppresses NF-kB, ERK-1/2 and JAK/
STAT pathways,58 in pancreatic beta cells 
stimulating CAMP/PKA signaling.59,60
 
CONCLUSIONS
Short-term isoflavone supplementation 
does not improve blood glucose levels 
in postmenopausal women, while other 
studies suggest long-term isoflavone 
supplementation can reduce postmenopausal 
blood glucose levels. These findings 
demonstrate that isoflavones as a component 
of flavonoids can be used to reduce blood 
glucose levels by three mechanisms: suppress 
gluconeogenic enzyme in hepar, increase 
lipogenesis, and stimulate glucose uptake 
and metabolism. Research on isoflavone 
supplementation in animals and humans in 
reducing blood glucose levels is still limited.
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